Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
INDIA – Swiss multinational Roche Pharma has announced the launch of PHESGO, the world’s first fixed dose combination of two monoclonal antibodies in oncology for the treatment of HER-2 positive…
Read More
AFRICA – According to a new study by Lancet Oncology, cancer deaths in sub-Saharan Africa (SSA) are projected to reach one million deaths a year by 2030 without rapid interventions.…
Read More
UNITED KINGDOM – National Health Service (NHS) England has unveiled a new test for infants in the womb to detect a rare form of eye cancer called retinoblastoma. The new…
Read More
GERMANY – Bayer has hired an oncology leader from GlaxoSmithKline for the second time this year, appointing Tara Frenkl, to lead oncology development for its oncology strategic business unit. Tara…
Read More
KENYA – Kenya has hosted the first ever Annual Comprehensive Hematology and Oncology Review (AnCHOR) organized by the International Cancer Institute (ICI) at the Eka Hotel in Eldoret, Uasin Gishu…
Read More
SWITZERLAND – The EU’s drug advisory body has recommended approval of Tecentriq (atezolizumab) as an adjuvant treatment in adult patients with early non-small-cell lung cancer (NSCLC) following complete resection and…
Read More
KENYA – Nakuru County Government in Kenya has launched an innovative digital health solution dubbed Empower Health System with an aim to improve on primary health care delivery for non-communicable…
Read More
USA – Regeneron Pharmaceuticals has shelled out US$250 million cash to acquire Checkmate Pharmaceuticals, a clinical-stage biotech developing drugs that activate the innate immune system. Regeneron will pay US$10.50 in…
Read More
UNITED KINGDOM – AstraZeneca and China-based Amoy Diagnostics (AmoyDx) have signed a master collaboration agreement for multiple companion diagnostics programs in China, the EU, and Japan. The agreement allows both…
Read More
UNITED KINGDOM – GlaxoSmithKline (GSK) sought to strengthen its cancer business on Wednesday by agreeing to a US$1.9 billion deal to acquire US drug developer Sierra Oncology, the latest move…
Read More